NRP1 and neoplasm: Results showed a much larger CD8+ T-cell infiltration in tumours obtained from mice treated with the anti-Nrp-1 i.p. plus anti-PD-1 combination than from mice treated with each mAb alone or the isotype control (Fig. 6h).